Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
US Department of Justice
Express Scripts
Farmers Insurance
Argus Health

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,399,567

« Back to Dashboard

Title: Method of treating cholera
Abstract:This invention discloses a method of treating cholera infection in a human by administering an effective amount of 1,5-dideoxy-1,5-imino-D-glucitol or a derivative thereof.
Inventor(s): Platt; Frances M. (Oxford, GB), Neises; Gabrielle R. (Chesterfield, MO), Dwek; Raymond A. (Oxford,, GB), Butters; Terry D. (Oxford,, GB)
Assignee: Monsanto Company (St. Louis, MO)
Filing Date:May 13, 1993
Application Number:08/061,645
Claims:1. A method of treating cholera in a human in need thereof comprising administering to said human a therapeutically effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which said alkyl contains from 2-8 carbon atoms.

2. The method of claim 1 in which the alkyl group contains from 4-6 carbon atoms.

3. The method of claim 1 in which the alkyl group is butyl.

4. The method of claim 1 in which the alkyl group is hexyl.

5. The method of claim 1 in which the therapeutically effective amount is from about 1 mg to about 100 mg per day.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.